Researchers devised an intervention that quickly integrates a cancer support team to guide caregivers and their patients through difficult end-of-life treatment and decisions.
A research team has created a new, self-assembling nanoparticle that can increase the effectiveness of magnetic resonance imaging (MRI) cancer detection.
In advanced cancer patients receiving opioids, methylprednisolone does not add to analgesic effect.
Physicians who diagnosed low-risk prostate cancer had more influence over the decision to enter active surveillance than did the disease characteristics, according to a case review.
HIV-infected individuals with cancer are less likely to receive treatment, according to a study published online in the Journal of Clinical Oncology.
Long-term central venous catheters (CVCs) are associated with an increased risk of infection in older adults with cancer, according to research published online.
Researchers have found that as antihistamines do their job, they also interfere with the function of myeloid-derived suppressor cells—a type of cell known to hinder the body's ability to combat tumors.
A landmark survey of more than 700 specialists provides crucial real-world insight into the treatments that most oncologists choose for lung cancer patients whose tumor has been incompletely resected.
A simple, noninvasive blood test matched with state-of-the-art molecular imaging of individual cells could help oncologists understand their patients' chances of survival.
Specialists who treat prostate cancer agree that active surveillance is an effective option—yet according to a study most don't recommend it when appropriate for their own patients.
A pilot program demonstrated that an acuity tool that accounts for more complex ambulatory infusion treatments allows nurses to increase their productivity.
A communication skills training program based on patient preferences regarding communication can help oncologists' communication performance, according to a study.
A national survey of patients reveals that physicians don't always fully discuss the risks and benefits of cancer screening, reports a new study.
People who survive cancer are likely to face a lifelong drain on their finances as they pay for mounting medical expenses year after year, a new government report finds.
One in five cancer patients typically wait more than three months to check in with a doctor about potentially serious symptoms, according to a new study.
Evidence to support reimbursement for proton-beam therapy remains limited to several relatively uncommon cancers.
Despite claims suggesting otherwise, inappropriate cancer patient demands are few and very rarely lead to unnecessary tests and treatments from their health care providers, according to new results.
New study challenges belief that inappropriate cancer treatments fuel health care costs, researcher says.
It is important to recognize and treat anxiety or depression among cancer patients, according to a clinical guideline published in the Journal of Clinical Oncology.
Adherence to established prostate cancer quality of care measures is frequently low, with considerable regional variation.
Mean blood pressures lower for nurses compared to readings made by doctors at same visit, according to research.
Plans to use multiplex tumor genetic testing and attitudes about results disclosure vary, with no clear consensus among clinicians.
As patients and oncology care teams strive to keep up with complex treatment plans, symptoms of distress in the patient may be missed. Distress screening tools can help nurse navigators identify which patients may need a referral for psychosocial support.
Mindfulness-based meditation is associated with a reduction in depressive symptoms in adolescents with cancer, with increased sleep quality for girls, according to a study.
About one-third of U.S. oncologists report being satisfied with work-life balance (WLB), which is lower than for other medical specialties. Women oncologists and those who devote greater time to patient care less likely to be satisfied.
Millions lack access to quality cancer care; one-quarter of uninsured forgo care because of costs.
Experts have identified three major sources of high cancer costs and argue that cancer doctors can likely reduce them without harm to patients. The cost-cutting proposals call for changes in routine clinical practice involved in end-of-life care, medical imaging, and drug pricing.
The journal Science named cancer immunotherapy as "the breakthrough of the year"; but challenges still remain to overcome tumor immune suppression and genomic instability.
Recent articles discussed the need to develop both a learning IT system for cancer that enables real-time data analysis from cancer patients in a variety of care settings.
This fact sheet reviews the use of laser light to to remove cancer or precancerous growths or to relieve symptoms of cancer.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|